Aciont gets $214K; Starpharma appoints exec;

> Aciont, based in Salt Lake City, has received $214,000 from the National Eye Institute and the National Institutes of Health to look into its ocular drug delivery system. Release

> Beginning in February 2011, Springer will launch a new peer-reviewed journal Drug Delivery and Translational Research, which will publish research on topics such as designing and developing novel drug delivery systems. Release

> Australia-based Starpharma has appointed Malcolm McColl to join the company's business development team as a vice president to meet the growing market demand for the company's dendrimer technology for drug delivery. Release